In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Buprenorphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.
Use the lowest effective dosage for the shortest duration consistent with individual patients treatment goals [see WARNINGS].
Buprenorphine hydrochloride is contraindicated in patients with:
Buprenorphine hydrochloride contains buprenorphine, a Schedule III controlled substance. As an opioid, buprenorphine...
The most frequent side effect in clinical studies involving 1,133 patients was sedation which occurred in approximately two-thirds of the patients. Although sedated, these patients could easily be aroused...
Buprenorphine hydrochloride contains buprenorphine, a Schedule III controlled substance.
Acute overdose with buprenorphine hydrochloride can be manifested by respiratory depression, somnolence progressing to stupor or coma...
Buprenorphine hydrochloride is a partial opioid agonist.
The chemical name of buprenorphine hydrochloride is 17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy 18,19-dihydro-3-hydroxy-6-methoxy-α-...
Buprenorphine is a partial agonist at the mµ-opioid receptor and an antagonist at the kappa-opioid receptor. One unusual...
Instructions for using the Carpuject™ Syringe are available with the reusable Carpuject™ Holder, List 2049-02.
Carpuject™ Single-dose cartridges are to be used ONLY with...
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.